H2020-SC1-BHC-2018-2020
H2020-SC1-BHC-2018-2020
- Programme
- H2020
- Funded projects (dataset)
- 234
- EU contribution (sum)
- €1,640,043,077
- Portal deadline
- —
Leading topic in historical projects: SC1-BHC-07-2019
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- INSERM13 coordinated
- UMC UTRECHT6 coordinated
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN5 coordinated
- ERASMUS MC5 coordinated
- KU Leuven5 coordinated
- RADBOUDUMC5 coordinated
- UU5 coordinated
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN4 coordinated
- DLR3 coordinated
- EF CLIF3 coordinated
- VHIR3 coordinated
- KI3 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- UNIVERSITEIT MAASTRICHT9 topic projects
- KING'S COLLEGE LONDON7 topic projects
- Leiden University Medical Center6 topic projects
- UNIVERSITY COLLEGE LONDON5 topic projects
- UNIGE4 topic projects
- CNRS4 topic projects
- CONCENTRIS RESEARCH MANAGEMENT GMBH4 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- RADBOUDUMC · STICHTING RADBOUD UNIVERSITEIT15 shared
NL ↔ NL
- INSERM · INSERM TRANSFERT SA13 shared
FR ↔ FR
- 11 shared
- STICHTING AMSTERDAM UMC · UMC UTRECHT9 shared
NL ↔ NL
- ERASMUS MC · STICHTING AMSTERDAM UMC8 shared
NL ↔ NL
- MINISTRY OF HEALTH · ISCIII8 shared
IT ↔ ES
- 8 shared
- ERASMUS MC · INSERM8 shared
NL ↔ FR
- 8 shared
- ERASMUS MC · EMBL8 shared
NL ↔ DE
- 8 shared
- 7 shared
- 7 shared
- INSERM · UMC UTRECHT7 shared
FR ↔ NL
- INSERM · STICHTING AMSTERDAM UMC7 shared
FR ↔ NL
- DLR · MINISTRY OF HEALTH7 shared
DE ↔ IT
- UNIVERSITY OF OSLO · OUS7 shared
NO ↔ NO
- 7 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 15.86
- Median orgs / project
- 14
- Min / max orgs
- 2 – 151
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Germany443
- Spain391
- Netherlands349
- France337
- Italy299
- United Kingdom295
- Belgium205
- Sweden125
- Switzerland110
- Finland92
- Denmark85
- Greece77
- Austria75
- Norway66
- Ireland65
- United States65
- Portugal49
- Czechia44
Organization types
- university484 orgs · 1511 rows
- research_institute398 orgs · 971 rows
- sme321 orgs · 393 rows
- public_body179 orgs · 323 rows
- other215 orgs · 290 rows
- company176 orgs · 223 rows
Topics in funded projects
- SC1-BHC-07-2019SC1-BHC-07-2019· 14 projects
- SC1-BHC-01-2019SC1-BHC-01-2019· 13 projects
- SC1-BHC-08-2020SC1-BHC-08-2020· 12 projects
- SC1-BHC-14-2019SC1-BHC-14-2019· 10 projects
- SC1-BHC-23-2018SC1-BHC-23-2018· 10 projects
- SC1-BHC-28-2019SC1-BHC-28-2019· 9 projects
- SC1-HCO-01-2018-2019-2020SC1-HCO-01-2018-2019-2020· 9 projects
- SC1-BHC-27-2018SC1-BHC-27-2018· 8 projects
- SC1-BHC-18-2018SC1-BHC-18-2018· 8 projects
- SC1-BHC-02-2019SC1-BHC-02-2019· 7 projects
- SC1-DTH-12-2020SC1-DTH-12-2020· 7 projects
- SC1-BHC-09-2018SC1-BHC-09-2018· 6 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| EJP RD European Joint Programme on Rare Diseases | H2020 | €55,073,831 |
| ECRAID-Base European Clinical Research Alliance on Infectious Diseases | H2020 | €29,969,875 |
| RISK-HUNT3R RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs | H2020 | €22,927,769 |
| DIAMONDS Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis | H2020 | €22,582,021 |
| CoroPrevention Personalized Prevention for Coronary Heart Disease | H2020 | €19,970,827 |
| PROFID Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction | H2020 | €19,884,570 |
| PrecisionTox Toward Precision Toxicology: New Approach Methodologies for Chemical Safety | H2020 | €19,305,584 |
| VEO Versatile Emerging infectious disease Observatory | H2020 | €18,118,386 |
| ONTOX Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment | H2020 | €17,211,050 |
| MICROB-PREDICT MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response | H2020 | €15,000,000 |
| DECIDER Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer | H2020 | €14,999,335 |
| SLEEP REVOLUTION Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therapeutics with health data integration | H2020 | €14,998,354 |
| UPGRADE Unlocking Precision Gene Therapy | H2020 | €14,995,830 |
| ONCOBIOME Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | H2020 | €14,994,551 |
| iPSpine Induced pluripotent stem cell-based therapy for spinal regeneration | H2020 | €14,959,781 |